BSX

Boston Scientific
D

BSX

Arincen84/100B

Boston Scientific executives and insider trading

Michael F. Mahoney bought 186,240 shares for 9.00M USD and sold 160,901 for 15.04M USD on the open market over the last twelve months.

Over the last twelve months Boston Scientific's insiders sold 178,214 shares for 16.80M USD in 3 sales on the open market, and bought 206,362 shares in 10 purchases.

Insiders over the last twelve months

Insider sales
3
Shares sold
178,214
Value sold
16.80M USD
Insider purchases
10

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
100.41K USD
3 months
0
10.04M USD
6 months
0
10.04M USD
1 year
16.80M USD
10.04M USD
2 years
134.15M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Michael F. Mahoney CEOChairman, President & Chief Executive Officer61160,90115.04M USD186,2402 Feb 2026252,241
Arthur Crosswell Butcher Executive Vice President and Group President of MedSurg & Asia Pacific5517,3131.76M USD—1 Dec 202557,894
Edward J Ludwig Director———8,580—30,359
David C Habiger Director———7,732—17,160
Susan E Morano Director———2,040—13,784
Cheryl Pegus Director———1,770—1,770

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
25 Aug 2026Susan E MoranoPurchase2,04049.22100.41K USD13,784Form 4
5 Aug 2026David C HabigerPurchase2,10047.5999.94K USD17,160Form 4
4 Aug 2026David C HabigerPurchase14048.596.80K USD15,060Form 4
3 Aug 2026David C HabigerPurchase1,04248.0750.08K USD14,920Form 4
3 Aug 2026Michael F. MahoneyPurchase186,24048.339.00M USD1,590,024Form 4
31 Jul 2026Edward J LudwigPurchase5,00045.48227.40K USD30,359Form 4
20 May 2026Cheryl PegusPurchase1,77056.4999.99K USD1,770Form 4
20 May 2026Edward J LudwigPurchase3,58056.68202.91K USD25,359Form 4
20 May 2026David C HabigerPurchase2,25055.92125.82K USD13,878Form 4
19 May 2026David C HabigerPurchase2,20056.95125.28K USD11,628Form 4
2 Feb 2026Michael F. MahoneySale1,20094.06112.87K USD1,571,436Form 4
2 Feb 2026Michael F. MahoneySale159,70193.4914.93M USD1,411,735Form 4
1 Dec 2025Arthur Crosswell ButcherSale17,313101.551.76M USD23,600Form 4
6 Nov 2025Ellen M ZaneSale12,89198.281.27M USD24,134Form 4
3 Nov 2025Joseph FitzgeraldSale3,600100.75362.69K USD224,742Form 4

Common questions about Boston Scientific's executives and insiders

Source: Financial Modeling Prep